An FDA Rejection, A Big Pharma Purchase, and Charting Watertown's Life Science Future -Watertown Bio News RoundUp
Plus another $10 million in VC raised, Souffle inks a partnership with Bayer, and more
Welcome to Watertown Bio
Soufflé Therapeutics Launches from Stealth, Disc and Werewolf receive FDA priority, Affini-T may be winding down.